We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 116

Law enforcement in the health care industry: what do new cases against Novartis tell us?

  • Morvillo Abramowitz Grand Iason & Anello PC
  • -
  • USA
  • -
  • May 9 2013

In recent years, pharmaceutical companies have faced criminal investigations and charges in regard to alleged off-label marketing of prescription

Jury ruled in Tuomey Healthcare retrial that the hospital violated the Stark Law and False Claims Act

  • King & Spalding LLP
  • -
  • USA
  • -
  • May 13 2013

On May 8, 2013, a jury concluded that Tuomey Healthcare System, Inc. (Tuomey), a community hospital in Sumter, S.C., violated the Stark Law for

Amphastar’s qui tam suit against Aventis shows importance of patents

  • Fish & Richardson PC
  • -
  • USA
  • -
  • May 3 2013

In a recent ground-breaking qui tam ruling, a California federal court denied Aventis Pharma's (a division of Sanofi-Aventis) efforts to dismiss

Tuomey violates Stark Law and False Claims Act through physician employment agreements

  • Barnes & Thornburg LLP
  • -
  • USA
  • -
  • May 13 2013

After a retrial, a federal jury found South Carolina-based 242-bed Tuomey Healthcare System (Tuomey) guilty last week of violating the Stark Law and

2012 year-end False Claims Act update

  • Gibson Dunn & Crutcher LLP
  • -
  • USA
  • -
  • January 8 2013

For years, the Department of Justice ("DOJ") has sought recoveries under the False Claims Act, 31 U.S.C. 3729-33 (the "FCA" or the "Act"), with a torrid

Gifts and favours to doctors are not a criminal offence

  • CMS Hasche Sigle
  • -
  • Germany
  • -
  • August 28 2012

The Federal Court of Justice has ruled that it is not a criminal offence for German doctors who have their own practice and are authorised to treat patients insured with a statutory healthcare fund to accept favours or gifts from pharmaceutical companies in return for prescribing particular drugs and medication

Important court decision for no-fault insurers: federal court rejects limitation on State Farm v. Mallela

  • Cadwalader Wickersham & Taft LLP
  • -
  • USA
  • -
  • January 9 2013

Specifically, on January 7, 2013, in the case of Allstate Ins. Co. v. Elzanaty, the United States District Court for the Eastern District of New York

Advice of counsel defense in US v. Lauren Stevens: dismissal of indictment is not necessarily good news for companies

  • Hogan Lovells
  • -
  • USA
  • -
  • March 25 2011

The indictment last November of former GlaxoSmithKline (GSK) in-house counsel, Lauren Stevens, for purportedly obstructing a U.S. Food and Drug Administration (FDA) investigation into whether GSK marketed Wellbutrin, an anti-depressant drug, off-label, falsifying and concealing documents, and making false statements sent shockwaves through the legal community

House of Lords confirms that price fixing can be criminal conspiracy to defraud strengthening NHS bargaining position and creating calls for OFT clarification

  • Shepherd & Wedderburn LLP
  • -
  • United Kingdom
  • -
  • March 12 2008

Two eagerly awaited House of Lords decisions were delivered today and have provided very useful clarity that price fixing can be prosecuted as common law conspiracy to defraud (in addition to prosecution under the Enterprise Act 2002) if aggravating factors, such as misrepresentation, are present

Denial of leave to amend securities complaint affirmed on basis of futility

  • Katten Muchin Rosenman LLP
  • -
  • USA
  • -
  • March 28 2008

The Court of Appeals for the Eighth Circuit affirmed a decision dismissing Plaintiff’s class action securities fraud complaint and denying Plaintiff leave to amend